In vivo imaging of cancer biomarkers using activatable molecular probes

Cancer Biomarkers : Section a of Disease Markers
Drew R EliasAndrew Tsourkas

Abstract

With the continued advancements in cellular and molecular biology, especially in the areas of genomics, proteomics and metabolomics, the scientific research community is gaining ground in uncovering the tortuous details associated with cancer. Molecular imaging has undergone a similar progression and is showing promise as a future method to aid in the early detection of malignancies, locating metastatic disease, staging tumors, evaluating the availability of therapeutic targets, and monitoring the efficacy of treatment. A subset of molecular imaging contrast agents known as "activatable molecular probes" has generated a particularly high level of excitement in the imaging community. Activatable molecular probes are designed to elicit a detectable change in signal upon enzymatic activity or in response to specific biomolecular interactions. In many cases, these unique characteristics allow for very high signal-to-background ratios compared with conventional targeted contrast agents and they open up the possibility of imaging intracellular targets. In this review, we will discuss some of the activatable probes recently developed for optical and magnetic resonance imaging platforms and their use in the visualization of cancer biom...Continue Reading

Citations

Feb 4, 2014·Nature Medicine·Frank J HernandezJames O McNamara
Apr 16, 2015·Contrast Media & Molecular Imaging·Sander M J van DuijnhovenHolger Grüll
Feb 20, 2015·European Radiology·Hebert Alberto VargasHedvig Hricak
Aug 12, 2016·Clinical and Translational Imaging : Reviews in Nuclear Medicine and Molecular Imaging·Marjolein HeukerMarleen van Oosten
Sep 3, 2013·Journal of Magnetic Resonance Imaging : JMRI·Angelique Louie
Oct 24, 2018·Journal of Biomedical Optics·Brian W Pogue, Brian C Wilson
Jan 24, 2018·Scientific Reports·Colin W K RosmanJan Maarten van Dijl
Jan 27, 2010·Contrast Media & Molecular Imaging·Raphael AlfordHisataka Kobayashi
Feb 11, 2011·Angewandte Chemie·Xin LinXiaoyuan Chen
May 25, 2012·Radiology·Moritz F Kircher, Jürgen K Willmann
Jun 26, 2015·FEMS Microbiology Reviews·Marleen van OostenGooitzen M van Dam
Apr 13, 2017·Macromolecular Rapid Communications·Dong CuiKanyi Pu
Mar 17, 2010·Chemical Reviews·Seulki LeeXiaoyuan Chen
Dec 22, 2016·Bioconjugate Chemistry·Qingqing Miao, Kanyi Pu
Sep 14, 2011·Journal of the American Chemical Society·Santimukul SantraJ Manuel Perez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.

Related Papers

American Journal of Nuclear Medicine and Molecular Imaging
Xinglu HuangXiaoyuan Chen
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
Katheryne E WilsonJürgen K Willmann
Current Topics in Medicinal Chemistry
Seulki LeeXiaoyuan Chen
Expert Review of Molecular Diagnostics
Evan Y Yu, David A Mankoff
Cancer Biomarkers : Section a of Disease Markers
Pei-Lin Hsiung, Thomas Wang
© 2021 Meta ULC. All rights reserved